わかもと製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4512/E00928 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/11/22 | 日証協 | 72,800株 | +3.41% | 15,100株 | -53.25% | 167,834株 | -30.8% | 6,700株 | -66.16% |
| 2018/11/16 | 日証協 | 70,400株 | +3.07% | 32,300株 | -48.57% | 242,534株 | +48.04% | 19,800株 | -83.18% |
| 2018/11/09 | 日証協 | 68,300株 | -8.08% | 62,800株 | +7.35% | 163,834株 | +40.71% | 117,700株 | +105.41% |
| 2018/11/02 | 日証協 | 74,300株 | +2.77% | 58,500株 | +83.96% | 116,434株 | -39.53% | 57,300株 | -43.38% |
| 2018/10/26 | 日証協 | 72,300株 | -32.62% | 31,800株 | -8.09% | 192,534株 | +52.4% | 101,200株 | +251.39% |
| 2018/10/19 | 日証協 | 107,300株 | -19.63% | 34,600株 | +4.85% | 126,334株 | -6.73% | 28,800株 | +3.23% |
| 2018/10/12 | 日証協 | 133,500株 | +4.79% | 33,000株 | +30.43% | 135,444株 | +8.32% | 27,900株 | +206.22% |
| 2018/10/05 | 日証協 | 127,400株 | -1.09% | 25,300株 | -16.78% | 125,044株 | +20.79% | 9,111株 | -27.11% |
| 2018/09/28 | 日証協 | 128,800株 | +6.1% | 30,400株 | +128.57% | 103,518株 | -17.73% | 12,500株 | +26.26% |
| 2018/09/21 | 日証協 | 121,400株 | +11.27% | 13,300株 | +17.55% | 125,833株 | -0.17% | 9,900株 | +3.12% |
| 2018/09/14 | 日証協 | 109,100株 | +2.63% | 11,314株 | +49.77% | 126,044株 | +0.24% | 9,600株 | +17.07% |
| 2018/09/07 | 日証協 | 106,300株 | -1.94% | 7,554株 | +220.9% | 125,744株 | +1.13% | 8,200株 | +290.48% |
| 2018/08/31 | 日証協 | 108,400株 | -1.63% | 2,354株 | -55.16% | 124,344株 | -0.24% | 2,100株 | -60.38% |
| 2018/08/24 | 日証協 | 110,200株 | -2.22% | 5,250株 | +9.38% | 124,644株 | -7.43% | 5,300株 | -69.36% |
| 2018/08/17 | 日証協 | 112,700株 | -9.11% | 4,800株 | -85.05% | 134,644株 | +4.91% | 17,300株 | +101.16% |
| 2018/08/10 | 日証協 | 124,000株 | -0.32% | 32,100株 | -8.84% | 128,344株 | -9.52% | 8,600株 | -15.69% |
| 2018/08/03 | 日証協 | 124,400株 | -6.61% | 35,212株 | +85.25% | 141,844株 | 0% | 10,200株 | +83.78% |
| 2018/07/27 | 日証協 | 133,200株 | +0.91% | 19,008株 | -51.94% | 141,844株 | -0.63% | 5,550株 | +208.33% |
| 2018/07/20 | 日証協 | 132,000株 | 0% | 39,550株 | 0% | 142,744株 | 0% | 1,800株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top